163 related articles for article (PubMed ID: 23824272)
21. Trichodysplasia Spinulosa in a 20-Month-Old Girl With a Good Response to Topical Cidofovir 1%.
Santesteban R; Feito M; Mayor A; Beato M; Ramos E; de Lucas R
Pediatrics; 2015 Dec; 136(6):e1646-9. PubMed ID: 26620059
[TBL] [Abstract][Full Text] [Related]
22. Cidofovir: to use or not to use?
Soma MA; Albert DM
Curr Opin Otolaryngol Head Neck Surg; 2008 Feb; 16(1):86-90. PubMed ID: 18197029
[TBL] [Abstract][Full Text] [Related]
23. [Squamous cell carcinoma arising in a giant condyloma acuminatum - Buschke-Löwenstein tumour].
Santos-Rancaño R; Cerdán C; Sanz G; Cerdán Miguel J
Cir Esp; 2013 Oct; 91(8):e43. PubMed ID: 23809201
[No Abstract] [Full Text] [Related]
24. Squamous cell carcinoma arising in a giant condyloma acuminatum (Buschke-Lowenstein tumour).
Chao MW; Gibbs P
Asian J Surg; 2005 Jul; 28(3):238-40. PubMed ID: 16024325
[TBL] [Abstract][Full Text] [Related]
25. Successful use of intralesional and intravenous cidofovir in association with indole-3-carbinol in an 8-year-old girl with pulmonary papillomatosis.
de Bilderling G; Bodart E; Lawson G; Tuerlinckx D; Remacle M; Naesens L; De Clercq E; Snoeck R
J Med Virol; 2005 Feb; 75(2):332-5. PubMed ID: 15602729
[TBL] [Abstract][Full Text] [Related]
26. Treatment of human polyomavirus-7-associated rash and pruritus with topical cidofovir in a lung transplant patient: Case report and literature review.
Smith SDB; Erdag G; Cuda JD; Rangwala S; Girardi N; Bibee K; Orens JB; Prono MD; Toptan T; Loss MJ
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29064138
[TBL] [Abstract][Full Text] [Related]
27. Should intralesional cidofovir be used for recurrent respiratory papillomatosis?
Donne A; Rothera M; Homer J
Clin Otolaryngol; 2010 Feb; 35(1):60. PubMed ID: 20447168
[No Abstract] [Full Text] [Related]
28. Successful treatment of giant condyloma in a pediatric heart transplant recipient with topical cidofovir.
Das BB; Anton K; Knox L; Jarin J; Sue PK
Transpl Infect Dis; 2018 Dec; 20(6):e12989. PubMed ID: 30184307
[TBL] [Abstract][Full Text] [Related]
29. Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice.
Smee DF; Bailey KW; Wong MH; Wandersee MK; Sidwell RW
J Infect Dis; 2004 Sep; 190(6):1132-9. PubMed ID: 15319864
[TBL] [Abstract][Full Text] [Related]
30. Topical cidofovir for severe warts in a patient affected by AIDS and Hodgkin's lymphoma.
De Socio GV; Simonetti S; Rosignoli D; Minga P; Tomassini GM; Baldelli F
Int J STD AIDS; 2008 Oct; 19(10):715-6. PubMed ID: 18824628
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of recalcitrant condyloma with topical cidofovir.
Hengge UR; Tietze G
Sex Transm Infect; 2000 Apr; 76(2):143. PubMed ID: 10858720
[No Abstract] [Full Text] [Related]
32. Chronic hypertrophic acyclovir-resistant genital herpes treated with topical cidofovir and with topical foscarnet at recurrence in an HIV-positive man.
Ghislanzoni M; Cusini M; Zerboni R; Alessi E
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):887-9. PubMed ID: 16898926
[No Abstract] [Full Text] [Related]
33. The treatment of viral warts with topical cidofovir 1%: our experience of seven paediatric patients.
Field S; Irvine AD; Kirby B
Br J Dermatol; 2009 Jan; 160(1):223-4. PubMed ID: 19067689
[No Abstract] [Full Text] [Related]
34. [Usefulness of topical cidofovir treatment for recalcitrant molluscum contagiosum in immunocompromised children].
Guérin M; Lepêcheur V; Rachieru-Sourisseau P; Réguerre Y; Pellier I; Martin L
Arch Pediatr; 2012 Nov; 19(11):1157-63. PubMed ID: 23037586
[TBL] [Abstract][Full Text] [Related]
35. A randomized, double-blind, placebo-controlled proof of concept trial of topical cidofovir, 1% and 3%, for the prevention of beard hair growth in men.
Wan J; Vittorio CC; Abuabara K; Kurd SK; Musiek A; Steinemann JM; Gelfand JM
Arch Dermatol; 2012 Feb; 148(2):257-9. PubMed ID: 22351834
[No Abstract] [Full Text] [Related]
36. Successful treatment with topical imiquimod of anal Buschke-Löwenstein tumor in a child.
Anissa Z; Houda HG; Wafa K; Olfa M; Rym BM; Achraf D; Samy F
Dermatol Ther; 2015; 28(6):363-5. PubMed ID: 26179407
[TBL] [Abstract][Full Text] [Related]
37. Oral topical cidofovir: novel route of drug delivery in a severely immunosuppressed patient with refractory multidrug-resistant herpes simplex virus infection.
Sims CR; Thompson K; Chemaly RF; Shpall EJ; Champlin RE; Safdar A
Transpl Infect Dis; 2007 Sep; 9(3):256-9. PubMed ID: 17605730
[TBL] [Abstract][Full Text] [Related]
38. Wiskott-Aldrich syndrome and molluscum contagiosum: a therapeutic challenge after reaction to cidofovir.
Hicks LD; Duvic M
Int J Dermatol; 2008 Dec; 47(12):1304-5. PubMed ID: 19126022
[No Abstract] [Full Text] [Related]
39. Topical cidofovir-induced acute kidney injury in two severely immunocompromised patients with refractory multidrug-resistant herpes simplex virus infections.
Saunders IM; Lahoti A; Chemaly RF; Trevino C; Westmoreland M; Hosing C
J Oncol Pharm Pract; 2016 Apr; 22(2):325-31. PubMed ID: 25488905
[TBL] [Abstract][Full Text] [Related]
40. [Intralesional cidofovir in human papilomavirus infection in interdigital spaces].
Pi Sala N; Figueras Suriol A; Ramió Montero E
Farm Hosp; 2017 Jan; 41(n01):132-133. PubMed ID: 28045657
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
